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Abstract: Methylxanthines are a group of substances derived from the purine base xanthine with
a methyl group at the nitrogen on position 3 and different residues at the nitrogen on position 1
and 7. They are widely consumed in nutrition and used as pharmaceuticals. Here we investigate
the transcriptional regulation of 83 genes linked to Alzheimer’s disease in the presence of five
methylxanthines, including the most prominent naturally occurring methylxanthines—caffeine,
theophylline and theobromine—and the synthetic methylxanthines pentoxifylline and propentofylline.
Methylxanthine-regulated genes were found in pathways involved in processes including oxidative
stress, lipid homeostasis, signal transduction, transcriptional regulation, as well as pathways involved
in neuronal function. Interestingly, multivariate analysis revealed different or inverse effects on gene
regulation for caffeine compared to the other methylxanthines, which was further substantiated by
multiple comparison analysis, pointing out a distinct role for caffeine in gene regulation. Our results
not only underline the beneficial effects of methylxanthines in the regulation of genes in neuroblastoma
wild-type cells linked to neurodegenerative diseases in general, but also demonstrate that individual
methylxanthines like caffeine mediate unique or inverse expression patterns. This suggests that the
replacement of single methylxanthines by others could result in unexpected effects, which could not
be anticipated by the comparison to other substances in this substance class.
Keywords: methylxanthines; caffeine; theobromine; theophylline; pentoxifylline; propentofylline;
oxidative stress; lipid homeostasis; energy metabolism; signal transduction
1. Introduction
Methylxanthines are derivatives of the purine base xanthine (2,6-dihydroxypurine) with additional
methyl groups at the nitrogen of the xanthine structure (R1, R2, R3) (Figure 1). The naturally occurring
methylxanthine caffeine is characterized by three additional methyl groups (1,3,7-trimethylxanthine),
whereas theophylline and theobromine have two additional methyl groups at different positions
(theophylline = 1,3-dimethylxanthine; theobromine = 3,7-dimethylxanthine). Synthetic methylxanthines
used as pharmaceuticals have, in addition to the methyl group at the R2 position, other functional groups
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at the R1 and R3 positions. For example, pentoxifylline has, in addition to the methyl groups at R2 and
R3, an oxohexyl group at R1 (3,7-dimethyl-1-(5-oxohexyl)purin-2,6-dion), and propentofylline has a
propylpurine group instead of a methyl group at R3 (3-methyl-1-(5-oxohexyl)-7-propylpurine-2,6-dione).
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consumed all over the world, being present in coffee, green and black tea and cacao [1,2]. A total of 
81.2% of the participants in a study investigating time trends of non-alcoholic beverage intake among 
German citizens declared a frequent consumption of coffee [3]. Coffee and green or black tea 
represent the second most commonly consumed non-alcoholic beverages, after water [4]. 
Methylxanthines can be easily absorbed from the digestive tract after oral intake and are known to 
have psychostimulant actions [5,6]. 
Aside from dietary uptake, xanthine derivatives are or have been widely used 
pharmacologically in veterinary and human medicine. For example, methylxanthines are reported to 
be beneficial for patients with chronic obstructive lung disease (COPD) and asthma by attenuating 
bronchial spasms [7] and for the treatment of respiratory pediatric diseases [8]. Since methylxanthines 
can cross the blood–brain barrier and influence the central nervous system via their effect as 
adenosine receptor antagonists, they are reported to have beneficial properties in respect of neuronal 
and neurodegenerative disorders like schizophrenia, Parkinson ś disease and Alzheimer ś disease 
(AD) [9–11]. In respect to coronary heart diseases, methylxanthines are reported to prevent 
hypertension, arterial thrombosis and myocardial infarction, as they have been shown to affect 
platelet function and arterial vasodilation [7,12]. In addition to their beneficial effects in treating the 
side effects of radiotherapy, individual methylxanthines are reported to be useful for biochemical 
modulation of cancer chemotherapy [13]. 
Methylxanthines act via different mechanisms, including antagonism of purinergic P1 receptors, 
mainly adenosine A1 and A2A receptors [14]. Blocking adenosine receptors reduces inhibitory 
endogenous adenosine and modulates several cellular pathways, e.g., by increasing dopaminergic 
activity in the brain and thereby mediating the psychostimulant effect. In higher concentrations, 
which cannot be reached by nutritional intake, but rather are reached through pharmaceutical intake, 
methylxanthines lead to inhibition of cyclic nucleotide phosphodiesterases and high-affinity ATP-
dependent cyclic nucleotide transporters, resulting in an increase of cellular cyclic AMP levels and 
mobilization of intracellular calcium; as a consequence a modulation of gamma-amino butyric acid 
receptors, for example, has been reported [15–18]. 
Methylxanthines affect gene transcription via different mechanisms. Naturally occurring 
methylxanthines effectively bind to all base pairs of native double helical DNA in a dose-dependent 
manner via hydrogen bond interaction [19]. Moreover, it has been shown that caffeine and 
theophylline are able to suppress the replication of human immunodeficiency virus type I (HIV-1) by 
inhibiting specific kinases that are important for retroviral DNA integration [20]. Theophylline used 
in therapeutic concentrations increases the activity of histone deacetylases. Regulating the histone 
deacetylases further results in the regulation of the transcription of inflammatory genes, for example, 
which has been reported in epithelial cells and macrophages [21]. However, the exact underlying 
molecular mechanism has yet to be elucidated [22]. Another potential mechanism of methylxanthines 
in regulating gene expression seems to include adenosine receptors. Methylxanthines bind to these 
receptors, which have a G-protein-dependent influence on the adenylate cyclase-mediated 
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The naturally occurring methylxanthines caffeine, theophylline and theobromine are widely
consumed all over the world, being present in coffee, green and black tea and cacao [1,2]. A total of
81.2% of the participants in a study investigating time trends of non-alcoholic beverage intake among
German citizens declared a frequent consumption of coffee [3]. Coffee and green or black tea represent
the second most commonly consumed non-alcoholic beverages, after water [4]. Methylxanthines can
be easily absorbed from the digestive tract after oral intake and are known to have psychostimulant
actions [5,6].
Aside from dietary uptake, xanthine derivatives are or have been widely used pharmacologically
in veterinary and human medicine. For example, methylxanthines are reported to be beneficial
for patients with chronic obstructive lung disease (COPD) and asthma by attenuating bronchial
spasms [7] and for the treatment of respiratory pediatric diseases [8]. Since methylxanthines
can cross the blood–brain barrier and influence the central nervous system via their effect as
adenosine receptor antagonists, they are reported to have beneficial properties in respect of neuronal
and neurodegenerative disorders like schizophrenia, Parkinson’s disease and Alzheimer’s disease
(AD) [9–11]. In respect to coronary heart diseases, methylxanthines are reported to prevent hypertension,
arterial thrombosis and myocardial infarction, as they have been shown to affect platelet function
and arterial vasodilation [7,12]. In addition to their beneficial effects in treating the side effects of
radiotherapy, individual methylxanthines are reported to be useful for biochemical modulation of
cancer chemotherapy [13].
Methylxanthines act via different mechanisms, including antagonism of purinergic P1 receptors,
mainly adenosine A1 and A2A receptors [14]. Blocking adenosine receptors reduces inhibitory
endogenous adenosine and modulates several cellular pathways, e.g., by increasing dopaminergic
activity in the brain and thereby mediating the psychostimulant effect. In higher concentrations,
which cannot be reached by nutritional intake, but rather are reached through pharmaceutical
intake, methylxanthines lead to inhibition of cyclic nucleotide phosphodiesterases and high-affinity
ATP-dependent cyclic nucleotide transporters, resulting in an increase of cellular cyclic AMP levels
and mobilization of intracellular calcium; as a consequence a modulation of gamma-amino butyric
acid receptors, for example, has been reported [15–18].
Methylxanthines affect gene transcription via different mechanisms. Naturally occurring
methylxanthines effectively bind to all base pairs of native double helical DNA in a dose-dependent
manner via hydrogen bond interaction [19]. Moreover, it has been shown that caffeine and theophylline
are able to suppress the replication of human immunodeficiency virus type I (HIV-1) by inhibiting
specific kinases that are important for retroviral DNA integration [20]. Theophylline used in therapeutic
concentrations increases the activity of histone deacetylases. Regulating the histone deacetylases
further results in the regulation of the transcription of inflammatory genes, for example, which has
been reported in epithelial cells and macrophages [21]. However, the exact underlying molecular
mechanism has yet to be elucidated [22]. Another potential mechanism of methylxanthines in
regulating gene expression seems to include adenosine receptors. Methylxanthines bind to these
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receptors, which have a G-protein-dependent influence on the adenylate cyclase-mediated conversion
of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). cAMP acts as an allosteric
effector for protein kinase A, which phosphorylates transcription factors like the cAMP response
element-binding protein (CREB) [23]. Interestingly, impairments in CREB signaling, which is important
for neuronal plasticity and the formation of long-term memory, can be linked to pathological conditions
occurring in neurodegenerative diseases like AD [24]. In addition to these mechanisms of action,
including adenosine receptors, direct interaction with DNA and modulation of histone deacetylases,
methylxanthines might also act directly, for example, as antioxidants.
In summary, methylxanthines are widely consumed and have a broad scope of application in
diseases, including neurodegenerative diseases like AD, Parkinson’s disease, Huntington’s disease
and multiple sclerosis. However, little is known about whether structural changes between the
xanthine derivatives caffeine, theobromine, theophylline, pentoxifylline and propentofylline may
mediate a unique function. In the present study, we therefore addressed the question of whether
these natural and synthetic methylxanthines exert different effects in respect to their transcriptional
properties on the expression of genes in neuroblastoma SH-SY5Y wild-type cells involved in
pathways related to neurodegenerative disorders, e.g., oxidative stress, lipid and energy metabolism,
signal transduction and gene expression, or Aβ- and tau-pathology and inflammation. The design of
the study is summarized in Figure 2. Eighty-three genes were selected that are known to be linked to
neurodegenerative diseases. Transcriptional changes induced by each analyzed xanthine derivative
in comparison to the solvent control were examined (A). Thereupon, we addressed the question of
whether there is a difference between the single methylxanthines, utilizing multiple comparison analysis
(B). To elucidate if these observed effects are specific for neuronal cells or are cell-type-independent,
more cell lines (HEPG2–liver and Calu-3–lung) (C) and different concentrations were analyzed (D).
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2. Results
2.1. Selection of Stable Housekeeping Genes
In accordance with the ∆∆CT method, quantitative real-time polymerase chain reaction (RT-PCR)
results are normalized to a housekeeping gene (HKG). One indispensable characteristic of the selected
housekeeping gene has to be a constant expression, which is independent of the investigated parameter.
To evaluate which housekeeping gene was not influenced by methylxanthines in this underlying study,
19 different genes, commonly used in the literature as HKGs [25–27], were selected. As well as a stable
expression, the HKG should have a comparable expression level to that of the gene being analyzed,
or, if several genes of interest are being analyzed, should cover a broad range of expression levels.
In line with this second requirement, the Cq values of the selected HKGs varied from 9.98 (RN18S1) to
22.81 (GPI) (see Figure 3A).
NormFinder was used to calculate a stability value for each gene, which enables a ranking of
the analyzed genes according to their stability (see Figure 3B). Based on these NormFinder results
and the expression level, we selected the five most stable HKGs covering a broad range of expression
for SH-SY5Y cells: GAPDH, GPI, RN18S1, TOP1 and YWHAZ. Importantly, these chosen HKGs
are linked to different cellular pathways (carbohydrate metabolism, glucose metabolism, protein
biosynthesis, transcription and signal transduction). For further analysis, the average Cq values of the
best five selected HKGs were used, making it even less likely that observed alterations were due to
coincidental changes in a single HKG. Additional information about the NormFinder results, and the
results leading to the selection of the HKGs utilized for the cell lines Calu-3 and HEPG2 are shown in
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values in SH-SY5Y cells after treatment with solvent control, caffeine, theophylline, pentoxifylline, 
theobromine or propentofylline. The five most stable HKGs are presented in bold letters. (B) 
Expression stability values for 19 analyzed genes calculated by the NormFinder algorithm. 
Classification of stability values in most stable genes (0 < stability value < 0.37; green), intermediate 
genes (0.37 < stability value < 0.53; yellow) and least stable genes (0.53 < stability value < 0.69; red) 
was done in accordance with Penna et al. [25]. HKGs are ranked from the least to the most stable from 
left to right and the five most stable genes selected for normalization in SH-SY5Y cells (RN18S1, GPI, 
TOP1, YWHAZ and GAPDH) are highlighted by a box. 
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2.2. Transcriptional Effects of Caffeine, Theobromine, Theophylline, Pentoxifylline and Propentofylline in
Neuronal Cells
As described above, methylxanthines can influence gene expression via several different
mechanisms, including receptor-mediated pathways, effect on DNA methylation or direct interaction
with DNA. Eighty-three genes were selected that are linked to neurodegenerative diseases including
pathways associated with oxidative stress, lipid- and energy-metabolism, signal transduction and gene
expression, Aβ- and tau-pathology and inflammation, as well as neuronal genes. The rationale for
selecting these genes and their potential link to neurodegenerative and other diseases are summarized
in Supplementary File S1. Interestingly, several of these pathways also affect diseases like coronary heart
disease, lung and liver diseases, which are also reported to be influenced by methylxanthines [7,8,28].
Here we evaluated the effect on the expression of genes involved in transversal biological processes,
especially genes linked to the five pathways listed in Figure 2. Potential alterations in gene expression
caused by methylxanthines found in this study are therefore mostly not specific to neurodegenerative
diseases but have to be considered as more common mechanisms relevant to a variety of diseases.
To address the question of whether methylxanthines influence the gene expression of the
abovementioned selected genes and pathways, human neuroblastoma cells (SH-SY5Y) were incubated
for 24 h with 100 µM of the xanthine derivatives or water as a solvent control. As methylxanthines,
caffeine (C), theobromine (TB), theophylline (TP), pentoxifylline (P) and propentofylline (PF) were
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chosen. These substances reflect the most widely consumed methylxanthines as nutrients (C, TP, TB)
or are synthetic methylxanthines used as a leading structure for further modifications (P, PF).
The use of 100 µM is slightly above the maximal plasma concentration observed in humans
(8–10 mg/L, approx. 50 µM [29]), however it has to be taken into consideration that caffeine is consumed
frequently over years and the experimental cell culture setting is a short 24 h incubation, which might
be the cause for widely using this concentration in other studies, showing no cytotoxicity and not
influencing cellular proliferation [11]. Moreover, it has to be mentioned that the maximum plasma
concentration of these compounds might be higher after pharmaceutical interventions than after
consumption as a nutrients in a diet.
After extraction of RNA and reverse transcription, RT-PCR was performed to analyze changes
in gene expression. Results are summarized in the heatmap shown in Figure 4A and a list of
individual effect strenghts, standard errors of the mean and p-values for each methylxanthine and
gene can be found in Supplementary File S3. The number of genes significantly up- or downregulated
by each analyzed methylxanthine is illustrated as a bar diagram next to the heatmap (Figure 4B).
To analyze the pattern, Fisher’s exact test was utilized, revealing that there are significant changes
in the distribution of down- and upregulated genes, especially for caffeine compared to the other
methylxanthines, suggesting that caffeine has unique, opposed or different effects compared to the
other methylxanthines.
In detail, caffeine significantly increased the expression of three oxidative stress-related genes
(PARK7, TXNRD2, ERCC2), whereas pentoxifylline, theobromine and propentofylline upregulated
the expression of two genes in this pathway (PRDX1, PRDX6). Propentofylline had the highest
downregulating effect on oxidative stress-related genes by significantly reducing the expression of four
different genes compared to the solvent control (PARK7, SOD1, TXNRD2, ERCC2). The expression of
two and three genes, respectively, were decreased by theophylline and theobromine in this pathway
(TP: TXNIP, ERCC2; TB: SOD1, ERCC2, ERCC6). In respect to lipid and energy metabolism, caffeine and
theobromine showed the most upregulating properties by influencing the transcription of three genes
respectively (C: HADH2, LPL, ERN1; TB: APOA1, LPL, AASS). Moreover, the expression of APOA1
was significantly increased after treatment with pentoxifylline and propentofylline. Theobromine
and propentofylline had an additional reducing influence on the expression of genes related to lipid
and energy metabolism by significantly decreasing the transcription of ABCA1 (TB and PF) and
HADH2 (PF). Three genes involved in pathways linked to signal transduction and gene expression
were significantly upregulated by caffeine treatment (PRKCQ, GNB2, EP300), whereas theobromine,
theophylline and propentofylline increased the expression of ALS2. In contrast to the increasing
impact of caffeine on GNB2 and EP300 expression, those genes were downregulated by theophylline,
theobromine, pentoxifylline and propentofylline. In respect to genes related to Aβ- and tau-pathology
and inflammation, caffeine had the most prominent upregulating effect by mediating a significant
increase in the transcription of GAP43, APBB2, UBQLN1, APH1b, CASP3, PSENEN, ECE2 and
CASP4. The expression of three genes involved in these pathways was increased by theophylline,
theobromine and propentofylline (A2M, PRNP, IL1A). Moreover, propentofylline has the most
pronounced downregulating effect by influencing the transcription of five genes involved in Aβ- and
tau-pathology and inflammation (APH1a, APH1b, PSENEN, ECE2, MMP2), followed by theobromine
(APH1a, APH1b, ECE2, LRP1), theophylline (APH1a, APH1b, ECE2) and pentoxifylline (APH1a, MMP2).
The following neuronal genes were significantly upregulated: PLAU by caffeine, ACHE by theophylline
and MAPT by theobromine (see Figure 4).
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Figure 4. Transcriptional influence of caffeine, theobromine, theophylline, pentoxifylline and
propentofylline in SH-SY5Y cells. (A) Transcriptional changes of genes related to the different
pathways involved in oxidative stress, lipid and energy metabolism, signal transduction and gene
expression, and Aβ- and tau-pathology and inflammation after treatment of human neuroblastoma
cells (SH-SY5Y) for 24 h with 100 µM of the analyzed xanthine derivatives, in comparison to the
solvent control, are illustrated in a heatmap. Fold changes greater than the standard deviation (yellow)
are highlighted in red when downregulated and in green when upregulated. (B) The number of
genes which are significantly changed by a single methylxanthine are summarized in a bar diagram.
To calculate the significance of the observed effects we first performed an ANOVA for each gene to
examine if there are differences in general. Afterwards, these p-values were adjusted with the false
discovery rate method over all 83 analyzed genes. To determine which methylxanthine significantly
changed the expression of a gene compared to the solvent control, we performed Dunnett’s test.
To examine if there are significant differences in the distribution patterns of the significantly down- or
upregulated genes influenced by the analyzed methylxanthines, we performed Fisher’s exact test.
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2.3. Comparison of Caffeine, Theobromine, Theophylline, Pentoxifylline and Propentofylline in Respect to their
Transcription-Regulatory Effects
Interestingly, the results described above reveal no uniform expression pattern between the single
methylxanthines, indicating the greatest difference between caffeine and the other xanthine derivatives.
By performing a principal component analysis (PCA) for each pathway, we were able to exemplify
how caffeine, theobromine, theophylline, pentoxifylline and propentofylline relate to each other in
this examined pathway (Figure 5, left). PCA serves to structure, simplify and illustrate a multivariate
data set by converting it into a two-dimensional data set consisting of two main components which
make up the largest percentage of variance in the multivariate dataset, in which component one
(x-axis) is more important than component two (y-axis). The genes which are included in these two
components can be found respectively in the loading plot for each pathway (see Supplementary File S6).
For oxidative stress, lipid and energy metabolism, signal transduction and gene expression, Aβ- and
tau-pathology and inflammation the PCA clearly showed a separation of caffeine from the other
analyzed methylxanthines in component one. In the group of neuronal genes, no clear separation in
component one could be observed, whereas a separation in component two between pentoxifylline
and theophylline can be found (for detailed information see Supplementary File S6).
To further clarify whether the separation of caffeine from the other xanthine derivatives, as
indicated in the PCA, was significant, we performed multiple comparison analysis with Tukey HSD
post-hoc test (individual p values are listed in Supplementary File S4). In regard to oxidative stress
caffeine regulates the expression of ERCC2, ERCC6, PARK7, and TXNRD2 significantly inversely in
comparison to theobromine, theophylline, pentoxifylline and propentofylline (see Figure 5, right bar
diagram). A similar result was obtained for genes related to lipid and energy metabolism. Examples
of the exclusive effect of caffeine are the expression of the genes ERN1 and HADH2. Analyzing
genes involved in signal transduction and gene expression, principal component analysis provides
strong evidences for a unique function of caffeine compared to the other xanthine derivatives. This
becomes even more obvious when the single genes are examined individually because three out of four
significantly changed genes in this pathway were contrarily regulated by caffeine compared to the other
methylxanthines (EP300, GNB2 and ALS2). In respect to Aβ- and tau-pathology and inflammation a
similar exclusive influence of caffeine became apparent. The expression of twelve out of 14 genes was
regulated in an opposite way by caffeine compared to the other analyzed xanthine derivatives (APBB2,
APH1a, APH1b, CASP3, CASP4, ECE2, GAP43, LRP1, MMP2, PSENEN and UBQLN1).
2.4. Analysis of Cell Type- and Dose-Dependence of the Observerd Methylxanthine-Mediated Effects
As mentioned above, the selected genes are only partially specific for neurodegenerative diseases
but are also affected in a variety of other diseases due to their common mechanisms. Therefore it is
reasonable to determine whether the observed effects are specific for neuronal cells or are also present
in other cell lines. We therefore analyzed Calu-3 and HEPG2 cells to identify gene regulatory effects
that are not limited to neuroblastoma SH-SY5Y cells. Calu-3 and HEPG2 cells were incubated under
comparable conditions (24 h duration and 100 µM concentration) and analyzed for overlapping effects
in the expression of those genes which were identified to be changed significantly compared to the
solvent control. The Venn diagram in Figure 6 illustrates those genes which showed a significant effect
calculated over all three cell lines. A detailed overview of the transcriptional changes is presented in
Supplementary File S5. Caffeine significantly upregulates the expression of APH1b (125.0% ± 9.4%,
p = 0.035) and PRKCQ (166.5% ± 52.6%, p = 0.029), whereas theobromine significantly increases
the transcription of ALS2 (161.1% ± 40.1%, p = 0.045), A2M (294.1% ± 126.2%, p = 0.008), ACHE
(175.0% ± 31.1%, p = 0.002) and MAPT (153.7% ± 14.5%, p = 0.036) over all three analyzed cell lines.
Theophylline significantly downregulates the expression of CASP4 (74.9% ± 5.0%, p = 0.017) and
pentoxifylline upregulates that of PRDX1 (141.9% ± 16.7%, p = 0.025) in a significant way, though it is
conserved in SH-SY5Y, HEPG2 and Calu-3 cells. The synthetic xanthine derivative propentofylline
increases the transcription of PRDX1 (148.6% ± 24.9%, p = 0.007), ACHE (161.7% ± 22.9%, p = 0.016),
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IDH1 (141.7% ± 22.6%, p = 0.026) and PRNP (133.6% ± 17.8%, p = 0.041) and reduces the expression of
CASP4 (78.1% ± 9.1%, p = 0.046) independently of the cell type.
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on the left. Fold changes and significances of those genes mediating the trends seen in the principal
component analysis are illustrated in a bar diagram on the right for each pathway. Standard error of
the mean is shown by the error bars and significance was calculated by Tukey’s honestly significant
difference (HSD) post-hoc test and set as * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001.
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Furthermore, we were interested in whether the alterations in the expressions are dose-dependent
effects of the analyzed methylxanthines. To examine effects in lower concentrations, we incubated
SH-SY5Y cells for 24 h additionally with 12.5µM, 25µM or 50µM of caffeine, theobromine, theophylline,
pentoxifylline or propentofylline. Those genes of which the expression was influenced in a similar
way by xanthine derivatives in all three analyzed cell lines were analyzed. By calculating the
correlation between housekeeping genes’ normalized Cq-values and the four different methylxanthine
concentrations, we found six genes to be regulated in a dose-dependent manner. The results for those
genes, namely APH1b, CASP4, ALS2, A2M, and ACHE, are shown in Figure 7. The expression of the
genes examined further did not correlate significantly with the analyzed methylxanthine concentrations
(caffeine: PRKCQ: r = 0.378, p = 0.622; pentoxifylline: PRDX1: r = 0.880, p = 0.120; theobromine: ACHE:
r = 0.943, p = 0.057; MAPT: r = 0.735, p = 0.256; propentofylline: PRDX1: r = 0.903, p = 0.097; IDH1:
r = 0.856, p = 0.144; PRNP: r = 0.761, p = 0.239).
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3. Discussion
Numerous beneficial effects of naturally occurring and synthetic methylxanthines are known.
This study was performed to clarify the influence of the methylated xanthine derivatives caffeine,
theobromine, theophylline, pentoxifylline and propentofylline on the expression of selected genes and
to detect potential differences between the methylxanthines. Our findings suggest that methylxanthines
are highly linked with oxidative stress, lipid and energy homeostasis, signal transduction and gene
expression, and pathways involved in neuronal function, since the expression of several genes related
to these pathways is altered due to incubation with methylxanthines, whereas the magnitude of effect
on target genes varies between the single analyzed xanthine derivatives.
Significant differences in the distribution of significantly regulated genes exist between caffeine
and the methylxanthines theobromine, theophylline, pentoxifylline and propentofylline. Moreover,
caffeine is the only xanthine derivative that had exclusively increasing transcriptional influences on
genes compared to the solvent control in each analyzed pathway. To further evaluate this indicated
trend for a unique function of caffeine, we performed principal component analysis combined with
multiple comparison analysis to examine if the methylxanthine-mediated effects on gene expression
differ significantly between the analyzed xanthine derivatives. In addition to common transcriptional
regulations of all methylxanthines, our study reveals that specific gene regulatory effects dependent on
the individual methylxanthine species, most of all caffeine, also exist.
A possible explanation could be a more potent binding of caffeine to adenosine receptors,
but referring to the inhibition constant (Ki-value) or IC50 values for A2A receptor it becomes obvious
that those values of theophylline, for example, are smaller than those of caffeine (Ki: 6.7 µM for
theophylline and 9.5 µM for caffeine [30]; IC50: 45 µM for theophylline and 98 µM for caffeine [1]).
Therefore, our findings indicate the existence of an additional, adenosine-receptor-independent
mechanism by which caffeine can influence gene expression.
Interestingly, it has been reported that caffeine itself has a beneficial effect or directly influences
enzymes in lower concentrations, whereas at higher concentrations its adenosine-receptor-mediated
effect is activated, resulting in gene regulatory effects which might contribute to the observed dose
dependency observed even at a concentration range below the IC50 of caffeine. In regard to oxidative
stress, it has been reported that methylxanthines have an antioxidative property by reducing the
reactive oxygen species (ROS) level itself. Moreover, an interaction of superoxide dismutase enzyme
(SOD) with caffeine was recently reported, resulting in a superimposed antioxidant activity and
suggesting SOD as an effective carrier of caffeine [31]. Another reason for the individual effects of the
methylxanthines might be a direct interaction with transcriptional regulators. Such an interaction has
been described for theophylline, which is able to restore corticosteroid responsiveness in COPD and
asthma patients through direct activation of the histone deacetylase (HDAC) [32].
A further reason for this exclusive function of caffeine compared to the other analyzed
methylxanthines could be the structural substitutions of the xanthine molecule. For numerous
physiologic effects, different pharmacological potencies for the xanthine derivatives caffeine,
theobromine and theophylline were reviewed by Monteiro and colleagues (2016). They summarized
that caffeine is effective in the stimulation of the central nervous system, whereas theophylline,
for example, is more effective in coronary dilatation. Additionally, the generally less active naturally
occurring methylxanthine theobromine is considered to be a potent cardiac stimulant. Moreover,
they assigned the substitutions in different positions of the xanthine molecule to affinity and selectivity
towards adenosine receptor sides and variant physiologic effects [33]. In line with this, several
pathways are described in the literature to be only or inversely influenced by caffeine in comparison
to other methylxanthines. In preclinical studies, caffeine showed a more pronounced effect on the
intracellular calcium concentration in ventricular myocytes compared to the other naturally occurring
methylxanthines theophylline and theobromine [34]. Furthermore, caffeine is administrated in infants
with bronchopulmonary dysplasia due to its beneficial antioxidative effects [35,36].
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To investigate the global transcriptional effects of methylated xanthines, we analyzed the expression
of genes of which the changes differ significantly between the incubated methylxanthines in the liver
cell line HEPG2 and the lung cancer cell line Calu-3. Examining effects which are independent of the
incubated cell type, we found that numerous genes associated with neuronal disorders were altered by
methylxanthines. The enzyme acetylcholinesterase (AChE), encoded by the gene ACHE, hydrolyzes the
neurotransmitter acetylcholine into choline and acetate, terminating neurotransmission [37]. In regard
to methylated xanthines, it was shown that caffeine can inhibit the activity of AChE and is therefore
linked to a neuroprotective effect in neurodegenerative diseases like AD [38]. APH1b encodes a
protein which is a functional component of the γ-secretase complex involved in the cleavage of
numerous substrates, for example amyloid-precursor-protein (APP) or notch. In a previous study
we showed that the activity of γ-secretase is influenced in the presence of methylxanthines [11]. An
additional effect of methylated xanthines on AD might be due to their transcriptionally effect on
A2M, a gene that encodes alpha-2-macroglobulin, known to be involved in Aβ homeostasis [39].
Moreover, we found the expression of MAPT to be influenced by methylxanthines. MAPT encodes
the microtubule-associated protein tau (MAPT), which is reported to be influenced by caffeine [40].
The gene PRNP encodes a membrane glycosylphosphatidylinositol-anchored glycoprotein, the major
prion protein PrP, of which the misfolded version is linked to numerous diseases [41]. It is reported
that caffeine is able to protect human neuronal cells against prion-mediated neurotoxicity due to
inducement of autophagy signals [42]. Regarding to inflammation, the protein caspase 4, which is
encoded by CASP4, is important for the execution phase of cell apoptosis and is an inducer of apoptosis
when overexpressed. A link between the presence of caffeine and a change in CASP4 expression is
described in the literature [43]. The guanine exchange factor ALS2, which is encoded by ALS2, as well
as the protein kinase C theta, encoded by PRKCQ, are proteins involved in signal transduction, which is
known to be influenced by caffeine and other methylated xanthines [44,45]. The cytoplasmic enzyme
NADP+-dependent isocitrate dehydrogenase 1 (IDH1) plays a crucial role in NADPH production
and is therefore important for the regeneration of reduced glutathione. Therefore, the activity of
this dehydrogenase can be correlated with cellular redox state since it is a key enzyme in cellular
defense against oxidative stress [46]. As these pathways are affected in many diseases, the broad
beneficial effects of methylxanthines can be explained. Our findings indicate a beneficial influence of
methylated xanthines on neuronal disorders and are in line with reports that the frequent consumption
of caffeine is linked with a lower incidence of Alzheimer’s disease and Parkinson’s disease [47,48].
A study analyzing the influence of caffeine on cholesterol-induced sporadic AD pathology, including
levels of the neurotoxic Aβ protein, the phosphorylation of tau and the generation of oxidative stress,
showed that a daily diet containing caffeine reversed the effects of the cholesterol-enriched diet and
suggested caffeine to be protective against sporadic AD-like pathology [49]. Interestingly, we found
global transcriptional effects of the analyzed methylxanthines on pathways involved in processes like
APP processing, defense against oxidative stress and inflammation, which could explain the beneficial
influence of xanthine derivatives on AD pathology and suggest their use for AD prevention and therapy.
Since the analyzed naturally occurring and synthetic methylxanthines also have individual effects on
specific genes, which might be helpful to address specific issues, these are especially important in
individualized medical approaches and should be a subject for further studies. Since we found different
transcriptional effects with a dependence on the concentration used, it has to be mentioned that it is
important to distinguish between concentrations that can be reached by nutritional intake and higher
concentrations of methylxanthines that can be reached only by pharmaceutical supplementation.
Based on our data, caffeine should be taken into consideration as a potential therapeutic approach
in different diseases, which are linked to the analyzed pathways and investigated genes, in particular
in Alzheimer’s disease, because this xanthine derivative shows several exclusive transcriptional effects
that could be beneficial for special patterns. However, it has to be mentioned that the results obtained
in this study are derived from cell culture experiments and have to be verified in vivo. Moreover,
we have evaluated whether methylxanthines alter gene expression, utilizing neuroblastoma wild-type
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cells. In these cells, genes were altered which are known to be affected in neurodegenerative diseases
in particular Alzheimer’s disease. However, since we investigated the effects of methylxanthines on
gene expression in wild-type cells, further experiments have to confirm whether methylxanthines can
revert or rescue neurodegenerative disease-mediated changes in gene expression, e.g., by investigating
effects of methylxanthines in Alzheimer’s disease models or clinical studies. Interestingly, besides this
caveat, we could confirm cell-type independent regulation for most robustly changed genes which also
showed a dose-dependent regulation.
4. Materials and Methods
4.1. Chemicals and Reagents
Caffeine, theophylline, TRizol Reagent, a High-Capacity cDNA Reverse Transcription Kit and
HPLC-grade H2O were acquired from Thermo Fisher Scientific (Waltham, MA, USA). Theobromine,
pentoxifylline, propentofylline and all other chemicals were purchased from Merck, formerly
Sigma-Aldrich (Darmstadt, Germany). The primers used in this study were synthesized from
Eurofins MWG Operon, Eberberg, Germany.
4.2. Cell Culture
The human neuroblastoma cell line SH-SY5Y wild-type was cultivated in Dulbecco’s modified
Eagle’s medium (DMEM) with 10% fetal calf serum (FCS, GE Healthcare Life Sciences, Chalfont St.
Giles, United Kingdom) and 1% non-essential amino acid solution at 37 ◦C and 5% CO2. For cultivation
of the liver hepatocellular carcinoma cell line HEPG2 wildtype, 1% penicillin/streptomycin was
additionally added to the medium. The lung cancer cell line Calu-3 wild-type was cultivated in
Dulbecco’s modified Eagle’s medium–F12 (DMEM F12) with 10% fetal calf serum (FCS, GE Healthcare
Life Sciences, Chalfont St. Giles, United Kingdom) at 37 ◦C and 5% CO2. All cells were seeded out
on six-well plates uniformly and cultivated to a confluency of 90%–100% before starting treatment
with methylxanthines.
4.3. Cell Treatment with Methylxanthines
Sixteen hours prior to incubation, the FCS content in the DMEM cultivation medium was lowered
to 0.1% FCS to preclude possible effects of the lipids present in FCS on the expression of fatty acid
metabolism related genes (for example). Caffeine, theobromine, theophylline, pentoxifylline and
propentofylline were incubated for 24 h (8 + 16 h) in a concentration of 100 µM, 50 µM, 25 µM or
12.5 µM and treatment with HPLC-grade H2O was performed as a solvent control.
4.4. Analysis of Gene Expression by RT-PCR Experiments
Quantitative real-time polymerase chain reaction (RT-PCR) experiments were performed after
isolation of total cellular RNA using the TRIzol reagent, according to the manufacturer’s guidelines.
The purity and concentration of the isolated RNA were analyzed by measuring their absorbance using
a NanoDrop2000 (Thermo Fisher Scientific, Waltham, Massachusetts, USA). To reduce the influence
of possible RNA contaminations, only samples with a 260/280 and 260/230 ratio ≥ 1.8 were used.
Two micrograms of RNA were reverse-transcribed to generate complementary DNA (cDNA) using
the High-Capacity cDNA Reverse Transcription Kit as described by the manufacturer. RT-PCR was
performed with the Fast SYBR green Master Mix (Applied Biosystems, Foster City, USA) and the
primers listed in Table 1 on a PikoReal Real-Time PCR System (Thermo Fisher Scientific, Waltham,
Massachusetts, USA). To preclude differences in RT efficiency, the five most stable housekeeping genes
(see Section 2.1, Selection of Stable Housekeeping Genes) were used for normalization.
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Table 1. RT-PCR primers used.
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Table 1. Cont.
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PSMB4 CTTGGTGTAGCCTATGAAGCCC CCAGAACTTCTCGCAGCAGAG [50]
RN18S1 GGAGTATGGTTGCAAAGCTGA ATCTGTCAATCCTGTCCGTGT [51]
RPL13A CCTGGAGGAGAAGAGGAAAGAGA TTGAGGACCTCTGTGTATTTGTCAA [26]
















YWHAZ ACTTTTGGTACATTGTGGCTTCAA CCGCCAGGACAAACCAGTAT [26]
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4.5. Stability Analysis of Housekeeping Genes via NormFinder Algorithm
To calculate the stability value for each housekeeping gene, we used the NormFinder algorithm,
published in [53] (https://moma.dk/normfinder-software), according to the authors’ manual via the
given R function.
4.6. Data Analysis
All quantified data represent an average of four independent incubations. In accordance with
the ∆∆CT method, ∆Cq values of each sample were calculated by subtracting the Cq value of each
single housekeeping gene from the Cq value of the gene of interest. This was performed for each
housekeeping gene, respectively. Afterwards, the ∆Cq values of each sample were transformed via the
2−∆Cq method and those values were averaged for the five housekeeping genes. Therefore, for every
gene of interest the normalization was done identically with the same housekeeping genes. Each
incubation was performed four independent times, which were analyzed in four independent real-time
PCRs, resulting in four independent 2−∆Cq values which were used to calculate the mean and standard
deviation. Fold changes were calculated using these 2−∆Cq values in relation to the solvent control,
which was set as 100 percent.
To calculate significant differences between the methylxanthine incubations and the solvent
control, analysis of variances (ANOVA) was performed. Obtained p-values were adjusted via the false
discovery rate (FDR) for all 83 genes to control type I errors. After a significant ANOVA, we performed
Dunnett’s test post hoc to investigate if significant differences to the solvent control existed for each
methylxanthine. Creation of the heatmap was performed with the help of the package “pheatmap”
(Raivo Kolde 2019; https://CRAN.R-project.org/package=pheatmap). To calculate significant differences
in the distribution of up- and downregulated significant genes for each methylxanthine, we carried out
Fisher’s exact test and p-values were adjusted via FDR.
Principal component analysis was carried out for each pathway, including genes which had
at least one significant change from a methylxanthine to the control. Loading plots showing the
correlation coefficients for each gene influencing component one and component two can be found
in Supplementary File S6. Additional post hoc analysis for each pathway was carried out similarly
to the earlier method, using Tukey’s honestly significant difference (HSD) test. Computation of
statistical significance and principle component analysis [54] were performed in R (R Core Team
2020; Vienna, Austria; https://www.R-project.org/). Error bar graphs represent standard error of the
mean. Correlation coefficients for dose-dependent effects were calculated via the Pearson method.
Significance was set at * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/21/23/
9015/s1.
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